Novus Biologicals™ RelA/NFkB p65 [p Ser529] Antibody Blocking Peptide

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide from human RelA/NFkB p65. Source: Synthetic The RelA/NFkB p65 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 5970
• Species: Human
• Purity: >95%
• Accession Number: Q04206, Q04206, Q04206, Q04206
• Content And Storage: Store at -20°C short term. Aliquot and store at -80°C long term. Avoid freeze-thaw cycles.
• Formulation: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
• For Use With (Application): Control Peptide Should be Used at 1.0 μg / 1.0 μL of Antiserum in / Assay.
• Gene Alias: MGC131774, nf kb p65, NFkB p65, NF-kB p65, NFKB3v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor ofkappa light polypeptide gene enhancer in B-cells 3 (p65)), Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 transcription factor p65, p65, RelA, rela p65, v-rel reticuloendotheliosis viral oncogene homolog A (avian), v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappalight polypeptide gene enhancer in B-cells 3, p65
• Gene Symbol: RELA
• Product Type: RelA/NFkB p65 Peptide
• Quantity: 0.05 mg
• Regulatory Status: RUO - research use only
• Source: Synthetic